CRLF2 and acute lymphoblastic leukemia: Previous study was found that approximately half of CRLF2-rearranged BCR-ABL1-like B-ALL cases exhibited concomitant activating mutations in JAK2, whereas such mutations were rare in non-CRLF2-rearranged cases [80].